Video

Episode 24 - Accountable Care Organizations

During this segment, David Calabrese, RPh, MHP, and Kenneth L. Schaecher, MD, FACP, CPC, discuss accountable care organizations (ACOs) and their impact on patient care.

Dr Schaecher explains that although ACOs are constructed to benefit healthcare professionals and patients, he fears that an ACO model of care may cause clinicians to under-utilize expensive drug

therapies.

Dr Schaecher hopes that healthcare professionals will continue to make the best choice for their patients and ignore the financial pressures that often play a role in the treatment decision-making process.


Newsletter

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Related Videos
David Awad, PharmD, BCOP
Coral Omene, MD, PhD, sitting for a vieo interview
Coral Omene, MD, PhD, sitting for a vieo interview
David Awad, PharmD, BCOP
Screenshot of Coral Omene, MD, PhD
H. John Beardsley, MBA, and Fauzea Hussain, MPH, sitting for a video interview
Adam Colborn, JD, associate vice president for congressional affairs, Academy of Managed Care Pharmacy (AMCP)
Eileen Peng, PharmD, sitting for a video interview
Related Content
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo